Results 71 to 80 of about 2,583,576 (275)

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Heavy menstrual bleeding (HMB) is a common presenting symptom in women with bleeding disorders, yet haemostatic testing is sometimes overlooked, even when refractory HMB requires surgical intervention. Aim To determine the prevalence of bleeding disorders in women referred for surgical management of HMB and investigate screening ...
Alison Delaney   +8 more
wiley   +1 more source

Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease

open access: yesTH Open, 2019
Background Management of atrial fibrillation (AF) is complex in patients with bleeding disorders. Catheter ablation such as pulmonary vein isolation (PVI) has been suggested in cases with bleeding disorders. However, data on safety are missing.
Paul R. van der Valk   +3 more
doaj   +1 more source

Sharp Bounds for Neuman Means in Terms of Geometric, Arithemtic and Quadratic Means [PDF]

open access: yesarXiv, 2014
In this paper, we find the greatest values $\alpha_{1}$, $\alpha_{2}$, $\alpha_{3}$, $\alpha_{4}$, $\alpha_{5}$, $\alpha_{6}$, $\alpha_{7}$, $\alpha_{8}$ and the least values $\beta_{1}$, $\beta_{2}$, $\beta_{3}$, $\beta_{4}$, $\beta_{5}$, $\beta_{6}$, $\beta_{7}$, $\beta_{8}$ such that the double inequalities $$A^{\alpha_{1}}(a,b)G^{1-\alpha_{1}}(a,b)<
arxiv  

Safety and Efficacy of Long‐Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Type 1 plasminogen deficiency (PLGD‐1), or hypoplasminogenaemia, is an ultra‐rare autosomal‐recessive disorder characterised by fibrin‐rich lesions on mucous membranes, often leading to serious complications if left untreated. Prior treatments have shown limited and inconsistent success, but IV PLG concentrate (Ryplazim) offers a ...
Amy D. Shapiro   +7 more
wiley   +1 more source

Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real‐Life Case Series and Literature Review

open access: yesHaemophilia, EarlyView.
ABSTRACT Background Acquired haemophilia A (AHA) is a rare and severe bleeding disorder generally associated with pregnancy or aging. Spontaneous remission and prompt inhibitor eradication are described more frequently in postpartum cases. We evaluated retrospectively 15 postpartum AHA cases between 2007 and 2023 in order to evaluate response in terms ...
Gaetano Giuffrida   +14 more
wiley   +1 more source

When a C*-algebra is a coefficient algebra for a given endomorphism [PDF]

open access: yesarXiv, 2005
The paper presents a criterion for a C*-algebra to be a coefficient algebra associated with a given ...
arxiv  

Singular Hochschild Cohomology and Gerstenhaber Algebra Structure [PDF]

open access: yesarXiv, 2015
In this paper, we define the singular Hochschild cohomology groups $HH_{sg}^i(A, A)$ of an associative $k$-algebra $A$ as morphisms from $A$ to $A[i]$ in the singular category $D_{sg}(A\otimes_k A^{op})$ for $i\in \mathbb{Z}$. We prove that $HH_{sg}^*(A, A)$ has a Gerstenhaber algebra structure and in the case of a symmetric algebra $A$, $HH_{sg}^*(A ...
arxiv  

Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Comorbidities and public health conditions in haemophilia are receiving increasing attention. Aim To analyse the prevalence of comorbidities and mortality in people with haemophilia (PwH) compared to matched controls in subgroups (factor consumption and sex).
Katarina Steen Carlsson   +8 more
wiley   +1 more source

Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests

open access: yesRomanian Journal of Laboratory Medicine
This study presents a transversal investigation that we performed at Fundeni hospital (Bucharest, Romania) into the therapeutic benefits and efficacy of Emicizumab, a non-factor therapy, in the context of hemophilia A.
Brinza Melen   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy